Cost, Effectiveness, and Cost-Effectiveness-Reference-Cited by-同舟云学术

Cost, Effectiveness, and Cost-Effectiveness

Published:2009-01 Issue:1 Volume:2 Page:49-54
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ: Cardiovascular Quality and Outcomes

Author:

Diamond George A.¹,Kaul Sanjay¹

Affiliation:

1. From the Division of Cardiology (G.A.D., S.K.) and the Cedars-Sinai Heart Institute (S.K.), Cedars-Sinai Medical Center, and the David Geffen School of Medicine (G.A.D.), University of California, Los Angeles, Calif.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCOUTCOMES.108.793406

Reference48 articles.

1. The Role of Cost-effectiveness Analysis in Health and Medicine

2. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine

3. Recommendations for Reporting Cost-effectiveness Analyses

4. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study

5. Neumann PJ. Using Cost-effectiveness Analysis to Improve Health Care: Opportunities and Barriers. Oxford University Press: New York; 2005.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand;Applied Health Economics and Health Policy;2024-06-10

2. Economic analyses in cardiac electrophysiology: from clinical efficacy to cost utility;Europace;2024-01-30

3. Sacubitril–Valsartan in Heart Failure: The Hard Sell of Spending More to Save Later;The American Journal of Cardiology;2023-09

4. What should neurointerventionalists know about cost-effectiveness research, and why should they care?;Journal of NeuroInterventional Surgery;2023-07-19

5. Optimal organ allocation policy under blood‐type barriers with the donor‐priority rule;Theoretical Economics;2022